GLP1R and type 2 diabetes mellitus: The glucose-dependent insulinotropic mechanism of GLP-1 RAs fundamentally transformed type 2 diabetes management by virtually eliminating hypoglycemia risk—a limitation that had constrained earlier antidiabetic therapies [58].